Annual Short Term Debt
$12.03 M
+$4.77 M+65.76%
December 31, 2024
Summary
- As of March 10, 2025, DNLI annual short term debt is $12.03 million, with the most recent change of +$4.77 million (+65.76%) on December 31, 2024.
- During the last 3 years, DNLI annual short term debt has risen by +$6.58 million (+120.69%).
- DNLI annual short term debt is now at all-time high.
Performance
DNLI Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$12.03 M
+$4.00 M+49.75%
December 31, 2024
Summary
- As of March 10, 2025, DNLI quarterly short term debt is $12.03 million, with the most recent change of +$4.00 million (+49.75%) on December 31, 2024.
- Over the past year, DNLI quarterly short term debt has stayed the same.
- DNLI quarterly short term debt is now at all-time high.
Performance
DNLI Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
DNLI Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +65.8% | 0.0% |
| 3 y3 years | +120.7% | 0.0% |
| 5 y5 years | +228.3% | 0.0% |
DNLI Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +120.7% | at high | +120.7% |
| 5 y | 5-year | at high | +228.3% | at high | +228.3% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Denali Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $12.03 M(+65.8%) | $12.03 M(+49.8%) |
| Sep 2024 | - | $8.04 M(+3.4%) |
| Jun 2024 | - | $7.77 M(+3.4%) |
| Mar 2024 | - | $7.51 M(+3.5%) |
| Dec 2023 | $7.26 M(-0.8%) | $7.26 M(+3.5%) |
| Sep 2023 | - | $7.01 M(+3.5%) |
| Jun 2023 | - | $6.77 M(+3.6%) |
| Mar 2023 | - | $6.54 M(-10.6%) |
| Dec 2022 | $7.32 M | $7.32 M(+3.5%) |
| Sep 2022 | - | $7.07 M(+20.4%) |
| Jun 2022 | - | $5.87 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $5.66 M(+3.8%) |
| Dec 2021 | $5.45 M(+16.3%) | $5.45 M(+3.8%) |
| Sep 2021 | - | $5.25 M(+3.9%) |
| Jun 2021 | - | $5.05 M(+3.7%) |
| Mar 2021 | - | $4.88 M(+4.0%) |
| Dec 2020 | $4.69 M(+28.0%) | $4.69 M(+4.0%) |
| Sep 2020 | - | $4.51 M(+4.1%) |
| Jun 2020 | - | $4.33 M(+5.1%) |
| Mar 2020 | - | $4.12 M(+12.4%) |
| Dec 2019 | $3.67 M(>+9900.0%) | $3.67 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Denali Therapeutics annual short term debt?
- What is the all time high annual short term debt for Denali Therapeutics?
- What is Denali Therapeutics annual short term debt year-on-year change?
- What is Denali Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Denali Therapeutics?
- What is Denali Therapeutics quarterly short term debt year-on-year change?
What is Denali Therapeutics annual short term debt?
The current annual short term debt of DNLI is $12.03 M
What is the all time high annual short term debt for Denali Therapeutics?
Denali Therapeutics all-time high annual short term debt is $12.03 M
What is Denali Therapeutics annual short term debt year-on-year change?
Over the past year, DNLI annual short term debt has changed by +$4.77 M (+65.76%)
What is Denali Therapeutics quarterly short term debt?
The current quarterly short term debt of DNLI is $12.03 M
What is the all time high quarterly short term debt for Denali Therapeutics?
Denali Therapeutics all-time high quarterly short term debt is $12.03 M
What is Denali Therapeutics quarterly short term debt year-on-year change?
Over the past year, DNLI quarterly short term debt has changed by $0.00 (0.00%)